Occupational exposure and health surveys at metal additive manufacturing facilities.

3D-printing additive manufacturing binder jetting metals occupational exposure occupational health particle exposure powder bed fusion

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 11 09 2023
accepted: 30 10 2023
medline: 7 12 2023
pubmed: 6 12 2023
entrez: 6 12 2023
Statut: epublish

Résumé

Additive manufacturing is a novel state-of-the art technology with significant economic and practical advantages, including the ability to produce complex structures on demand while reducing the need of stocking materials and products. Additive manufacturing is a technology that is here to stay; however, new technologies bring new challenges, not only technical but also from an occupational health and safety perspective. Herein, leading Swedish companies using metal additive manufacturing were studied with the aim of investigating occupational exposure and the utility of chosen exposure- and clinical markers as predictors of potential exposure-related health risks. Exposure levels were investigated by analysis of airborne dust and metals, alongside particle counting instruments measuring airborne particles in the range of 10 nm-10 μm to identify dusty work tasks. Health examinations were performed on a total of 48 additive manufacturing workers and 39 controls. All participants completed a questionnaire, underwent spirometry, and blood and urine sampling. A subset underwent further lung function tests. Exposure to inhalable dust and metals were low, but particle counting instruments identified specific work tasks with high particle emissions. Examined health parameters were well within reference values on a group level. However, statistical analysis implied an impact on workers kidney function and possible airway inflammation. The methodology was successful for investigating exposure-related health risks in additive manufacturing. However, most participants have been working <5 years. Therefore, long-term studies are needed before we can conclusively accept or reject the observed effects on health.

Identifiants

pubmed: 38054074
doi: 10.3389/fpubh.2023.1292420
pmc: PMC10694287
doi:

Substances chimiques

Air Pollutants, Occupational 0
Dust 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1292420

Informations de copyright

Copyright © 2023 Assenhöj, Almstrand, Kokelj, Ljunggren, Olin and Karlsson.

Déclaration de conflit d'intérêts

A-CA and AO are shareholders of PEXA AB and AO is a board member. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Respir Res. 2009 Sep 30;10:90
pubmed: 19793393
Am J Respir Crit Care Med. 2011 Sep 1;184(5):602-15
pubmed: 21885636
Environ Pollut. 2023 Jan 15;317:120727
pubmed: 36427825
Lung India. 2016 Jul-Aug;33(4):410-6
pubmed: 27578934
Environ Res. 2020 Sep;188:109770
pubmed: 32544723
Soc Sci Med. 1995 Feb;40(4):491-502
pubmed: 7725123
Chemosphere. 2020 Nov;259:127452
pubmed: 32629313
PLoS One. 2021 Mar 18;16(3):e0248601
pubmed: 33735215
Biophys J. 2008 Feb 1;94(3):855-68
pubmed: 17890383
Environ Res. 2013 Apr;122:81-7
pubmed: 23453847
Ups J Med Sci. 1986;91(3):299-310
pubmed: 3811032
Ann Work Expo Health. 2021 Apr 22;65(3):332-345
pubmed: 33599259
Metabolism. 1995 Dec;44(12):1536-9
pubmed: 8786720
Ann Work Expo Health. 2022 Nov 15;66(9):1111-1121
pubmed: 35211721
Am J Physiol Lung Cell Mol Physiol. 2000 Feb;278(2):L305-11
pubmed: 10666114
Respir Med. 2016 Aug;117:92-102
pubmed: 27492518
Am J Ind Med. 2019 Feb;62(2):99-110
pubmed: 30615207
Environ Res. 2022 May 1;207:112110
pubmed: 34614394
Am J Respir Crit Care Med. 2005 Apr 15;171(8):912-30
pubmed: 15817806
Nephrol Dial Transplant. 2008 Apr;23(4):1252-6
pubmed: 17986474
Clin Chem. 1998 Aug;44(8 Pt 1):1641-9
pubmed: 9702950
Environ Sci Pollut Res Int. 2023 Mar;30(13):35769-35780
pubmed: 36538233
BMJ. 2018 Aug 29;362:k3310
pubmed: 30158148
Front Public Health. 2023 Apr 17;11:1148974
pubmed: 37151597
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3359-3368.e1
pubmed: 33930619
PLoS One. 2021 Jun 25;16(6):e0253825
pubmed: 34170967
Int Arch Occup Environ Health. 1999 Jul;72(4):261-7
pubmed: 10491781
Eur Respir J. 2003 Dec;22(6):1026-41
pubmed: 14680096
PLoS One. 2021 Aug 31;16(8):e0256746
pubmed: 34464420
Clin Chem Lab Med. 2022 Jul 04;60(9):1426-1439
pubmed: 35786502
Int J Environ Res Public Health. 2022 Sep 11;19(18):
pubmed: 36141707
Saf Health Work. 2019 Dec;10(4):518-526
pubmed: 31890335
Ann Am Thorac Soc. 2021 Feb;18(2):238-246
pubmed: 33090904
Int J Hyg Environ Health. 2017 Apr;220(2 Pt B):341-363
pubmed: 27931767
Int Arch Occup Environ Health. 2022 Aug;95(6):1255-1265
pubmed: 35066624
J Occup Environ Hyg. 2021 Jun;18(6):223-236
pubmed: 33989129
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Indoor Air. 2001 Dec;11(4):217-22
pubmed: 11761596
J Clin Lipidol. 2018 Jan - Feb;12(1):193-202
pubmed: 29146227
Sci Rep. 2022 Apr 4;12(1):5620
pubmed: 35379863
J Occup Med Toxicol. 2022 Jul 25;17(1):14
pubmed: 35879723
Bull Eur Physiopathol Respir. 1985 Nov-Dec;21(6):551-7
pubmed: 4074961
J Asthma. 2018 Dec;55(12):1343-1351
pubmed: 29300537
Int J Hyg Environ Health. 2021 Apr;233:113693
pubmed: 33581414
Part Fibre Toxicol. 2014 May 13;11:23
pubmed: 24885771
Handb Exp Pharmacol. 2015;224:207-28
pubmed: 25522989
Chest. 2007 Oct;132(4):1275-82
pubmed: 17890470
J Occup Environ Med. 2007 Jun;49(6):641-50
pubmed: 17563607
Proteome Sci. 2011 Jun 28;9(1):34
pubmed: 21711511
Am J Cardiol. 2007 Jul 15;100(2):217-21
pubmed: 17631073
Occup Environ Med. 2022 Jun;79(6):380-387
pubmed: 35121651
Am J Physiol Lung Cell Mol Physiol. 2002 Feb;282(2):L330-9
pubmed: 11792638
Biol Trace Elem Res. 2023 Dec;201(12):5607-5615
pubmed: 36929113
Curr Epidemiol Rep. 2019 Mar;6(1):50-66
pubmed: 31080703
Int J Environ Res Public Health. 2020 Aug 13;17(16):
pubmed: 32823696
Environ Res. 2010 Jul;110(5):497-504
pubmed: 20381026
Ann Work Expo Health. 2021 Jul 3;65(6):617-634
pubmed: 33616163
J Breath Res. 2018 Sep 14;12(4):046012
pubmed: 30102246
J Toxicol Environ Health B Crit Rev. 2021 Jun 17;:1-50
pubmed: 34139957
J Clin Pathol. 1983 Mar;36(3):253-9
pubmed: 6186698

Auteurs

Maria Assenhöj (M)

Occupational and Environmental Medicine Center in Linköping, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

Ann-Charlotte Almstrand (AC)

Occupational and Environmental Medicine, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.

Spela Kokelj (S)

Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.

Stefan A Ljunggren (SA)

Occupational and Environmental Medicine Center in Linköping, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

Anna-Carin Olin (AC)

Occupational and Environmental Medicine, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.

Helen Karlsson (H)

Occupational and Environmental Medicine Center in Linköping, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH